It is important to understand the molecular mechanisms and underlying biology of CD133-associated cancer stem cells in a milieu of heterogeneous, non-tumor cells such as tumor-infiltrating stromal cells for a proper evaluation of this prognostic marker. This evidence concerns the gene PROM1 and cancer.